Point-Of-Care, Decentralized CAR-T Manufacturing
Source: Cell & Gene
In this segment, our panelists deliberate on the feasibility of decentralized, point-of-care (POC) CAR-T manufacturing. They highlight the common concerns and challenges associated with POC manufacturing — especially as it relates to maintaining product quality across different sites. Our experts also highlight concerns with the decentralized model’s scalability. While future innovations (e.g., automation) may address some of these concerns, the panelists concede: when it comes to adopting POC manufacturing, the field has to walk before it can run.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
This website uses cookies to ensure you get the best experience on our website. Learn more